These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23494569)

  • 1. Immunotoxin targeting EpCAM effectively inhibits peritoneal tumor growth in experimental models of mucinous peritoneal surface malignancies.
    Flatmark K; Guldvik IJ; Svensson H; Fleten KG; Flørenes VA; Reed W; Giercksky KE; Fodstad Ø; Andersson Y
    Int J Cancer; 2013 Sep; 133(6):1497-506. PubMed ID: 23494569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting tumor-associated macrophages in an experimental glioma model with a recombinant immunotoxin to folate receptor beta.
    Nagai T; Tanaka M; Tsuneyoshi Y; Xu B; Michie SA; Hasui K; Hirano H; Arita K; Matsuyama T
    Cancer Immunol Immunother; 2009 Oct; 58(10):1577-86. PubMed ID: 19238383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MOC31PE immunotoxin - targeting peritoneal metastasis from epithelial ovarian cancer.
    Andersson Y; Haavardtun SI; Davidson B; Dørum A; Fleten KG; Fodstad Ø; Flatmark K
    Oncotarget; 2017 Sep; 8(37):61800-61809. PubMed ID: 28977905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered Anti-GPC3 Immunotoxin, HN3-ABD-T20, Produces Regression in Mouse Liver Cancer Xenografts Through Prolonged Serum Retention.
    Fleming BD; Urban DJ; Hall MD; Longerich T; Greten TF; Pastan I; Ho M
    Hepatology; 2020 May; 71(5):1696-1711. PubMed ID: 31520528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotoxin treatment targeted to the high-molecular-weight melanoma-associated antigen prolonging the survival of immunodeficient rats with invasive intracranial human glioblastoma multiforme.
    Hjortland GO; Garman-Vik SS; Juell S; Olsen OE; Hirschberg H; Fodstad O; Engebraaten O
    J Neurosurg; 2004 Feb; 100(2):320-7. PubMed ID: 15086240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel immunotoxin recognising the epithelial glycoprotein-2 has potent antitumoural activity on chemotherapy-resistant lung cancer.
    Zimmermann S; Wels W; Froesch BA; Gerstmayer B; Stahel RA; Zangemeister-Wittke U
    Cancer Immunol Immunother; 1997 Mar; 44(1):1-9. PubMed ID: 9111578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-PSMA immunotoxin as novel treatment for prostate cancer? High and specific antitumor activity on human prostate xenograft tumors in SCID mice.
    Wolf P; Alt K; Bühler P; Katzenwadel A; Wetterauer U; Tacke M; Elsässer-Beile U
    Prostate; 2008 Feb; 68(2):129-38. PubMed ID: 18044731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo imaging of immunotoxin treatment using Katushka-transfected A-431 cells in a murine xenograft tumour model.
    Pardo A; Stöcker M; Kampmeier F; Melmer G; Fischer R; Thepen T; Barth S
    Cancer Immunol Immunother; 2012 Oct; 61(10):1617-26. PubMed ID: 22350071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HER2-targeted immunotoxins with low nonspecific toxicity and immunogenicity.
    Guo R; Cao L; Guo W; Liu H; Xu H; Fang Q; Hong Z
    Biochem Biophys Res Commun; 2016 Jun; 475(1):93-9. PubMed ID: 27178207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and modification of EGF4KDEL 7Mut, a novel bispecific ligand-directed toxin, with decreased immunogenicity and potent anti-mesothelioma activity.
    Stish BJ; Oh S; Chen H; Dudek AZ; Kratzke RA; Vallera DA
    Br J Cancer; 2009 Oct; 101(7):1114-23. PubMed ID: 19755995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical assessment of an anti-EpCAM immunotoxin: locoregional delivery provides a safer alternative to systemic administration.
    Brown J; Rasamoelisolo M; Spearman M; Bosc D; Cizeau J; Entwistle J; MacDonald GC
    Cancer Biother Radiopharm; 2009 Aug; 24(4):477-87. PubMed ID: 19694583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting malignant B cells with an immunotoxin against ROR1.
    Baskar S; Wiestner A; Wilson WH; Pastan I; Rader C
    MAbs; 2012; 4(3):349-61. PubMed ID: 22531447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAT-8015: a second-generation pseudomonas exotoxin A-based immunotherapy targeting CD22-expressing hematologic malignancies.
    Alderson RF; Kreitman RJ; Chen T; Yeung P; Herbst R; Fox JA; Pastan I
    Clin Cancer Res; 2009 Feb; 15(3):832-9. PubMed ID: 19188153
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Chang J; Liu X; Ren H; Lu S; Li M; Zhang S; Zhao K; Li H; Zhou X; Peng L; Liu Z; Hu P
    Mol Pharm; 2021 Jun; 18(6):2285-2297. PubMed ID: 33998814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery.
    Prada-Villaverde A; Esquivel J; Lowy AM; Markman M; Chua T; Pelz J; Baratti D; Baumgartner JM; Berri R; Bretcha-Boix P; Deraco M; Flores-Ayala G; Glehen O; Gomez-Portilla A; González-Moreno S; Goodman M; Halkia E; Kusamura S; Moller M; Passot G; Pocard M; Salti G; Sardi A; Senthil M; Spiliotis J; Torres-Melero J; Turaga K; Trout R
    J Surg Oncol; 2014 Dec; 110(7):779-85. PubMed ID: 25088304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of an immunotoxin to folate receptor beta on bleomycin-induced experimental pulmonary fibrosis.
    Nagai T; Tanaka M; Hasui K; Shirahama H; Kitajima S; Yonezawa S; Xu B; Matsuyama T
    Clin Exp Immunol; 2010 Aug; 161(2):348-56. PubMed ID: 20550546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting a Cancer-Specific Epitope of the Epidermal Growth Factor Receptor in Triple-Negative Breast Cancer.
    Simon N; Antignani A; Sarnovsky R; Hewitt SM; FitzGerald D
    J Natl Cancer Inst; 2016 Aug; 108(8):. PubMed ID: 27075852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotoxins in the treatment of refractory hairy cell leukemia.
    Kreitman RJ; Pastan I
    Hematol Oncol Clin North Am; 2006 Oct; 20(5):1137-51, viii. PubMed ID: 16990113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An immunotoxin targeting the gH glycoprotein of KSHV for selective killing of cells in the lytic phase of infection.
    Cai Y; Berger EA
    Antiviral Res; 2011 Jun; 90(3):143-50. PubMed ID: 21440007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel Treatment with Intraperitoneal MOC31PE Immunotoxin in Colorectal Peritoneal Metastasis: Results From the ImmunoPeCa Phase 1 Trial.
    Frøysnes IS; Andersson Y; Larsen SG; Davidson B; Øien JT; Olsen KH; Giercksky KE; Julsrud L; Fodstad Ø; Dueland S; Flatmark K
    Ann Surg Oncol; 2017 Jul; 24(7):1916-1922. PubMed ID: 28224367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.